RT Journal Article
SR Electronic
T1 Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002296
DO 10.1136/jitc-2020-002296
VO 9
IS 6
A1 Duerinck, Johnny
A1 Schwarze, Julia Katharina
A1 Awada, Gil
A1 Tijtgat, Jens
A1 Vaeyens, Freya
A1 Bertels, Cleo
A1 Geens, Wietse
A1 Klein, Samuel
A1 Seynaeve, Laura
A1 Cras, Louise
A1 D’Haene, Nicky
A1 Michotte, Alex
A1 Caljon, Ben
A1 Salmon, Isabelle
A1 Bruneau, Michaël
A1 Kockx, Mark
A1 Van Dooren, Sonia
A1 Vanbinst, Anne-Marie
A1 Everaert, Hendrik
A1 Forsyth, Ramses
A1 Neyns, Bart
YR 2021
UL http://jitc.bmj.com/content/9/6/e002296.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.